DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...

Travere Therapeutics recently reached a new 52-week high after investors reacted to regulatory updates for its rare kidney disease therapy FILSPARI, including the removal of an FDA advisory committee ...

A job posting by a Microsoft engineer sparked excitement about a project “to eliminate every line of C and C++ from Microsoft ...

The latest update is out from VistaGen Therapeutics ( (VTGN) ).

FP-001 42 mg is an investigational, sustained-release formulation of a GnRH agonist being developed for the treatment of CPP. It is designed to provide continuous suppression of gonadotropin secretion ...

In a quarterly report filed with the U.S. Securities and Exchange Commission on November 14, 2025 ( SEC filing ), TREMBLANT CAPITAL GROUP disclosed a new position in CyberArk Software Ltd.

Gaurav Sheth of Kroll says modern MDR must pair AI, identity telemetry and machine-speed response to cut business impact as ...

Growth at OAC Technology has come from an unusual place for a managed IT firm: steady work and quiet referrals rather than a ...

The tech firm reveals a focus on AI agents, Copilot expansion, Microsoft 365 updates, and global infrastructure investment.

The "Network Detection and Response (NDR) Market, 2024-2029" report has been added to ResearchAndMarkets.com's offering. The revenue estimate for 2024 is $2.61 billion, with a CAGR of 23.1% for the ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry.Singapore, December 24, 2025 ...

The United States is increasingly governed by reversal. Policies are launched with urgency, amplified with incentives and ...